Salix Pharmaceuticals, Ltd.'s Antibiotic Xifaxan Effective in Easing Bowel Syndrome in Mid-Stage Study

Bloomberg -- Salix Pharmaceuticals Ltd.’s antibiotic Xifaxan helped relieve symptoms such as abdominal pain in patients with a type of irritable bowel syndrome, according to two trials funded by the drugmaker.
MORE ON THIS TOPIC